Skin and eyelid inflammation affects millions of people every year. Over 85% of patients also suffer from inflammatory ocular conditions such as Meibomian Gland Dysfunction (MGD), blepharitis, eyelid inflammation and eyelid telangiectasia.
Dr Elizabeth Raymond Brown
Laser and light based technologies are integral to a wide range of medical and cosmetic interventions – from plastic surgery to tattoo removal. Intense light sources, such as the Lumenis M22 platform, are a proven modality for hair reduction and skin rejuvenation including the treatment of telangiectasia, rosacea and acne. Recently, intense light sources have been reported to be a promising therapy in the treatment of dry eye syndrome caused by meibomian gland dysfunction (MGD).
This talk will review the fundamentals of laser and light based devices and describe the chromophores that can be targeted by laser and light devices. The presentation will discuss the principles of light-tissue interactions, looking in particular at the concepts of using intense light sources for the treatment of ocular rosacea and meibomian gland dysfunction (MGD).
Dr Rolando Toyos
Saturday, December 10, 2016 10:00 AM - 3:30 PMGMT Time
Royal Society of Medicine1 Wimpole StreetLondon W1G 0AEUnited Kingdom020 7290 2900
Cvent Online Event Registration Software | Copyright © 2000-2017 Cvent, Inc. All rights reserved.